“…However, currently, PNA administration has become a useful tool in treating young persons and even children. Indeed, positive effects of cladribine in the treatment of chronic lymphocytic leukemia have been described (Chow et al 2000), as its efficacy in treating NHL [Chow et al 2000], mantle cell lymphoma (Inwards et al 2008), AML (Wierzbowska et al 2008), myelodysplastic syndromes (Laurencet et al 1997), chronic myeloid leukemia (Martinelli et al 1996), Waldenström macroglobulinemia (Rourke et al 2010), histiocytosis, also in children (Mottl et al 2006), astrocytomas (Ceruti et al 2000, Ceruti et al 2003), multiple sclerosis (Hartung 2009; Leist and Weissert 2011; Vosoughi and Freedman 2010), mast cell disease (Aichberger et al 2008), psoriasis, including psoriatic arthritis (Eibschutz et al 1995), systemic lupus erythematosus (Bernknopf et al 2011), angioedema, and anaphylaxis (Dutta et al 2002). …”